Citations

Clear

3138 citation(s) found for "Smith, AM".

Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation
Regan, Kevin M., Wang, Diping, Smith, David I, Deursen, Jan M. A. van, Tindall, Donald J., Huang, Haojie , Wang, Fang , Smith, David I

Mayo Clinic

Proceedings of the National Academy of Sciences | January 24, 2005 | Volume: 102 | Issue: 5 | Pages: 1649-1654

10.1073/pnas.0406789102 | PMID 15668399 Get It

Forkhead transcription factors FOXO1 (FKHR), FOXO3a (FKHRL1), and FOXO4 (AFX) play a pivotal role in tumor suppression by inducing growth arrest and apoptosis. Loss of function of these factors due to phosphorylation and proteasomal degradation has been implicated in cell transformation and malignancy. However, the ubiquitin ligase necessary for the ubiquitination of the FOXO factors and the relevance of this regulation to tumorigenesis have not been characterized. Here we demonstrate that Skp2, an oncogenic subunit of the Skp1/Cul1/F-box protein ubiquitin complex, interacts with, ubiquitinates, and promotes the degradation of FOXO1. This effect of Skp2 requires Akt-specific phosphorylation of FOXO1 at Ser-256. Moreover, expression of Skp2 inhibits transactivation of FOXO1 and abolishes the inhibitory effect of FOXO1 on cell proliferation and survival. Furthermore, expression of the FOXO1 protein is lost in a mouse lymphoma model, where Skp2 is overexpressed. These data suggest that the Skp2-promoted proteolysis of FOXO1 plays a key role in tumorigenesis.
The “Moving Valgus Stress Test” for Medial Collateral Ligament Tears of the Elbow
O’Driscoll, Shawn W. , Lawton, Richard L., Smith, Adam , Fitzsimmons, James S

Mayo Clinic

The American Journal of Sports Medicine | December 20, 2004 | Volume: 33 | Issue: 2 | Pages: 231-239

10.1177/0363546504267804 | PMID 15701609 Get It

Background The diagnosis of a painful partial tear of the medial collateral ligament in overhead-throwing athletes is challenging, even for experienced elbow surgeons and despite the use of sophisticated imaging techniques. Hypothesis The “moving valgus stress test” is an accurate physical examination technique for diagnosis of medial collateral ligament attenuation in the elbow. Study Design Cohort study (diagnosis); Level of evidence, 2. Methods Twenty-one patients underwent surgical intervention for medial elbow pain due to medial collateral ligament insufficiency or other abnormality of chronic valgus overload, and they were assessed preoperatively with an examination called the moving valgus stress test. To perform the moving valgus stress test, the examiner applies and maintains a constant moderate valgus torque to the fully flexed elbow and then quickly extends the elbow. The test is positive if the medial elbow pain is reproduced at the medial collateral ligament and is at maximum between 120 ° and 70 °. Results The moving valgus stress test was highly sensitive (100%, 17 of 17 patients) and specific (75%, 3 of 4 patients) when compared to assessment of the medial collateral ligament by surgical exploration or arthroscopic valgus stress testing. The mean shear range (ie, the arc within which pain was produced with the moving valgus stress test) was 120 ° to 70 °. The mean angle at which pain was at a maximum was 90 ° of elbow flexion. Conclusions The moving valgus stress test is an accurate physical examination technique that, when performed and interpreted correctly, is highly sensitive for medial elbow pain arising from the medial collateral ligament.
In Vivo Expression of Recombinant Vascular Endothelial Growth Factor in Rabbit Carotid Artery Increases Production of Superoxide Anion
Suda, Osamu, Peterson, Timothy E., Katušić, Zvonimir S. , Smith, Leslie , d’Uscio, Livius V.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | December 17, 2004 | Volume: 25 | Issue: 3 | Pages: 506-511

10.1161/01.atv.0000153284.81572.f0 | PMID 15604414 Get It

Objective— Vascular endothelial growth factor (VEGF) is one of the most important pro-angiogenic cytokines. Ability of VEGF to stimulate formation of superoxide anion in vivo has not been studied. We hypothesized that in vivo expression of recombinant VEGF in the rabbit carotid artery increases production of superoxide anion. Methods and Results— Plaque-forming units (10 9 ) of adenovirus-encoding human VEGF 165 (AdVEGF) or β-galactosidase (AdLacZ) were delivered into the lumen of rabbit carotid arteries. Three days after gene delivery, expression of recombinant proteins was detected in endothelium and smooth muscle cells. Endothelium-dependent relaxations to acetylcholine were impaired in AdVEGF-transduced arteries ( P <0.01; n=5). Treatment with superoxide dismutase mimetic, Mn(III) tetra(4-benzoic acid) porphyrin chloride (10 −5 mol/L), improved relaxations to acetylcholine ( P <0.01; n=5). Western blot analysis demonstrated increased expression of p47 phox in AdVEGF-transduced arteries ( P <0.05; n=8). Lucigenin chemiluminescence showed significantly higher production of superoxide anion in AdVEGF-transduced arteries ( P <0.05; n=5 to 10). Conclusions— Our results suggest that in vivo expression of recombinant VEGF in the vascular endothelium increases local production of superoxide anion. Superoxide anion appears to be an important mediator of vascular effects of VEGF in vivo.
185 A NOVEL AND EFFECTIVE PROCEDURE FOR REMOVING HIV-1 AND HEPATITIS B AND C VIRUSES FROM SPIKED HUMAN SEMEN
Loskutoff, N.M., Huyser, Carin, Morfeld, K.A., Thornhill, Alan R., Morris, L, Webber, Lynne M. , Singh, Ruby , Walker, David , Smith, Maree T.

Mayo Clinic

Reproduction, Fertility and Development | December 14, 2004 | Volume: 17 | Issue: 2 | Pages: 243-243

10.1071/rdv17n2ab185 Get It

The objectives of this study were to determine the effectiveness of a novel, trypsinized density gradient treatment designed to remove viruses from semen and to evaluate sperm viability after treatment. Exp. 1: Cryopreserved human semen (n = 6 donors) was layered on 2-mL columns of 45% Isolate (Irvine Scientific, Santa Ana, CA, USA) with or without 0.25% trypsin (trypsin-exposed and control, respectively), which overlaid 2-mL columns of 90% Isolate with or without 10 µg/mL soy-based trypsin inactivator (Sigma, St. Louis, MO, USA) and centrifuged (700g for 30 min). The layering of multiple density gradients is facilitated by a novel polypropylene tube insert, which also prevents contamination when extracting treated sperm (USA and international patents pending). Pellets were washed and then incubated at room temperature. Sperm were examined (motility and supravital staining) at 0, 2, 24, and 48 h post-treatment and the results evaluated using Wilcoxon Signed Rank and Rank Sum tests. Exp. 2: A cytopathic cell (MT-2) assay was conducted (6 replicates) to determine the effect of trypsin (1-min exposure) on HIV-1 RNA infectivity. Viral replication was assessed by syncytium formation and p24 antigen production. Exp. 3: Two pools of fresh human semen (N1 = 3 and N2 = 8 donors) were inoculated (1:1) with 1 × 108 copies/mL of cultured HIV-1 RNA, and one pool (N2) was inoculated (1:1) with plasma collected from patients infected with either Hepatitis B DNA (HBV) or C (HCV) RNA viruses; spiked and non-spiked aliquots were processed as in Exp. 1. Treated sperm pellets were analyzed for HIV-1 or HBV and HCV concentrations by the Bayer Versant branched DNA (bDNA; version 3.0) and/or the Roche Amplicor quantitative RT-PCR (1.5 ultrasensitive) assays at Toga Laboratories (Pty), Ltd. (Edenvale, South Africa). As a result of Exp. 1, there was significantly (P &lt; 0.05) lower motility (but not supravital staining) between trypsin-treated and control sperm at 0 h (58.0 vs. 69.3%) and 2 h (54.7 vs. 62.9%) post-washing; however, no differences were noted after 24 h (P &gt; 0.05). In Exp. 2, trypsin exposure affected HIV-1 RNA infectivity negatively as compared to controls in terms of MT-2 cell syncytium formation and p24 antigen production. Results of the bDNA and/or RT-PCR assays in Exp. 3 indicated that the procedure effectively reduced HIV-1, HBV, and HCV viral copies in the spiked semen samples to undetectable levels or levels below clinical relevance. In conclusion, the novel trypsin density gradient procedure was effective for removing HIV-1, HBV and HCV from spiked semen without markedly affecting sperm survival. Extrapolation of these results to natural infections may be unfounded for viruses (e.g. HBV) that are thought to integrate into sperm chromatin.
Malignant pheochromocytoma: current status and initiatives for future progress
Eisenhofer, Graeme , Bornstein, Stefan R. , Brouwers, Frederieke M., Cheung, Nai‐Kong V. , Giordano, Thomas J. , Lehnert, Hendrik, Manger, William M., Neumann, Hartmut P.H., Pacák, Karel , Shulkin, Barry L. , Smith, David I, Tischler, Arthur S. , Dahia, Patricia L. M. , Krijger, Ronald R. de , Greene, Lloyd A. , Goldstein, David S. , Maris, John M. , Smith, David I, Young, William F. , Shulkin, Barry L

Mayo Clinic

Endocrine-Related Cancer | December 2, 2004 | Volume: 11 | Issue: 3 | Pages: 423-436

10.1677/erc.1.00829 | PMID 15369446 Get It

Abstract Pheochromocytomas are rare catecholamine-producing neuroendocrine tumors that are usually benign, but which may also present as or develop into a malignancy. Predicting such behavior is notoriously difficult and there are currently no curative treatments for malignant tumors. This report follows from a workshop at the Banbury Conference Center, Cold Spring Harbor, New York, on the 16th–18th November 2003, held to review the state of science and to facilitate future progress in the diagnosis and treatment of malignant pheochromocytoma. The rarity of the tumor and the resulting fragmented nature of studies, typically involving small numbers of patients, represent limiting factors to the development of effective treatments and diagnostic or prognostic markers for malignant disease. Such development is being facilitated by the availability of new genomics-based tools, but for such approaches to succeed ultimately requires comprehensive clinical studies involving large numbers of patients, stringently collected clinical data and tumor samples, and interdisciplinary collaborations among multiple specialist centers. Nevertheless, the well-characterized hereditary basis and the unique functional nature of these neuroendocrine tumors provide a useful framework that offers advantages for establishing the pathways of tumorigenesis and malignancy. Such findings may have relevance for understanding the basis of other more common malignancies where similar frameworks are not available. As the relevant pathways leading to pheochromocytoma are established it should be possible to take advantage of the new generation of drugs being developed to target specific pathways in other malignancies. Again the success of this will require well-designed and coordinated multicenter studies.
Expression and Function of Recombinant S1179D Endothelial NO Synthase in Human Pial Arteries
Sorenson, Joseph, Santhanam, Anantha Vijay R., Akiyama, Masahiko, Sessa, William C. , Katušić, Zvonimir S. , Smith, Leslie

Mayo Clinic

Stroke | November 30, 2004 | Volume: 36 | Issue: 1 | Pages: 158-160

10.1161/01.str.0000150489.47080.67 | PMID 15569867 Get It

Background and Purpose— Mutation of serine 1179 to aspartate on the endothelial NO synthase (eNOS) increases NO production in the absence of stimulation by agonists. The present study was designed to determine the effect of recombinant S1179DeNOS gene expression on the vasomotor function of human pial arteries. Methods— Pial arteries were isolated from 28 patients undergoing temporal lobectomy for intractable seizures. Adenoviral vectors (10 10 pfu/mL) encoding β-galactosidase (AdCMVLacZ) or S1179DeNOS (AdCMVS1179DeNOS) were used for ex vivo gene transfer, and vasomotor function was evaluated in control and transduced arteries. Results— Contractions to cumulative additions of U46619 were not affected by expression of LacZ or S1179DeNOS. Endothelium-dependent relaxations to bradykinin or endothelium-independent relaxations to Diethylaminodiazen-1-ium-1,2-dioate were significantly reduced in arteries expressing S1179DeNOS. A superoxide dismutase mimetic, manganese (III) tetrakis (4-benzoic acid) porphyrin chloride, failed to improve the reduced relaxations to bradykinin. The levels of cGMP were significantly elevated in arteries expressing S1179DeNOS. Conclusions— Our results support the concept that high local production of NO in pial arterial wall causes adaptive reduction of vasodilator reactivity to NO.
Transplantation of Circulating Endothelial Progenitor Cells Restores Endothelial Function of Denuded Rabbit Carotid Arteries
He, Tongrong , Harrington, Sean C., Nath, Karl A. , Caplice, Noel M. , Katušić, Zvonimir S. , Smith, Leslie

Mayo Clinic

Stroke | September 3, 2004 | Volume: 35 | Issue: 10 | Pages: 2378-2384

10.1161/01.str.0000141893.33677.5d | PMID 15345801 Get It

Background and Purpose— Circulating endothelial progenitor cells (EPCs) play an important role in repair of injured vascular endothelium and neovascularization. The present study was designed to determine the effect of EPCs transplantation on the regeneration of endothelium and recovery of endothelial function in denuded carotid arteries. Methods— Isolated mononuclear cells from rabbit peripheral blood were cultured in endothelial growth medium for 7 days, yielding EPCs. A rabbit model of common carotid artery denudation by passage of a deflated balloon catheter was used to evaluate the effects of EPCs on endothelial regeneration and vasomotor function. Immediately after denudation, autologous EPCs (10 5 cells in 200 μL saline) or 200 μL saline alone (control) were administered into the lumen of injured artery. Results— Four weeks after transplantation, fluorescence-labeled colonies of EPCs were found in the vessel wall. Local transplantation of EPCs as compared with saline administration accelerated endothelialization and significantly improved endothelium-dependent relaxation when assessed 4 weeks after denudation (n=4 to 5, P <0.05). Transplantation of EPCs did not affect vasomotor function of arterial smooth muscle cells. Protein array analysis of conditioned media obtained from cultured EPCs demonstrated the ability of these cells to produce and release a number of proangiogenic cytokines. Conclusions— We conclude that local delivery of cultured circulating EPCs into the lumen of denuded carotid arteries accelerates endothelialization and improves endothelial function. Paracrine effects of EPCs may contribute to regenerative properties of EPCs.
Evaluation of the TRUGENE HCV 5′NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical Specimens
Germer, Jeffrey J., Rosser, Michael, Thompson, Amber , Mitchell, P. Shawn, Smith, Thomas F., Elagin, Slava, Yao, Joseph D. , Majewski, David

Mayo Clinic

Journal of Clinical Microbiology | August 5, 2004 | Volume: 42 | Issue: 8 | Pages: 3911-3911

10.1128/jcm.42.8.3911.2004 Get It

Response of the Clinical Microbiology Laboratory to Emerging (New) and Reemerging Infectious Diseases
Cockerill, Franklin R., Smith, Thomas F.

Mayo Clinic

Journal of Clinical Microbiology | June 7, 2004 | Volume: 42 | Issue: 6 | Pages: 2359-2365

10.1128/jcm.42.6.2359-2365.2004 | PMID 15184405 Get It

The TALE Homeodomain Protein Pbx2 Is Not Essential for Development and Long-Term Survival
Selleri, Licia , DiMartino, Jorge, Deursen, Jan van, Brendolan, Andrea , Sanyal, Mrinmoy , Boon, Elles M. J., Smith, Kevin S. , Rhee, Joon Whan, Pöpperl, Heike, Grosveld, Gerard C. , Cleary, Michael L. , Capellini, Terence D.

Mayo Clinic

Molecular and Cellular Biology | May 28, 2004 | Volume: 24 | Issue: 12 | Pages: 5324-5331

10.1128/mcb.24.12.5324-5331.2004 | PMID 15169896 Get It